A Web-Based Dyadic Intervention for Colorectal Cancer
Part of paid clinical trials in Atlanta, Georgia.
- Sponsor
- Emory University
- Study ID
- NCT05663203
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Internet-Based Intervention — OTHERAttend CRCWeb intervention
- Interview — OTHERComplete interview
- Survey Administration — OTHERComplete survey
- Electronic Health Record Review — OTHERMedical records are reviewed
Study Details
This clinical trial studies how well a web-based dyadic intervention works to manage psychoneurological symptoms for patients with colorectal cancer and their caregivers. Patients with colorectal cancer receiving chemotherapy experience severe and distressing psychoneurological symptoms that include fatigue, depression, sleep disturbance, pain, and cognitive dysfunction. When these co-occurring symptoms are undertreated, they negatively affect functional status, survival rates, and quality of life of patients as well as decrease health outcomes of their family caregiver. A critical need exists to develop an effective and novel intervention that focuses on patients with colorectal cancer receiving chemotherapy and their caregivers. A web-based dyadic intervention holds great promise to reduce psychoneurological symptoms burden and improve quality of life for patients with colorectal cancer receiving chemotherapy and advance intervention development and implementation in cancer supportive care and health equity.
Key Dates
- Start date
- May 1, 2023
- Status verified
- Dec 2025
- Primary completion
- Oct 1, 2026
- Completion
- Oct 1, 2027
Study Design
- Enrollment
- 56 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Supportive care (CRCWeb intervention)Patients and caregivers attend a CRCweb intervention over 8 weeks. Patients and caregivers complete interviews and surveys throughout the trial.
Primary Outcome Measure
Attrition Rate [ Time Frame: Up to week 8 ]
Central Contacts
- Yufen Lin, PhD, RN404-712-9823
- Canhua Xiao, PhD, RN404-712-9823
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Emory University/Winship Cancer Institute | Atlanta | Georgia | 30322 |
Find similar trials in Atlanta, GA
Related Studies
- Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsPHASE1/PHASE2 · Recruiting · Children's Oncology Group · Birmingham, Alabama
- Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology ClinicsRecruiting · Wake Forest University Health Sciences · Fairbanks, Alaska
- A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or PancreasPHASE1 · Recruiting · Boehringer Ingelheim · Los Angeles, California
- Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent TreatmentPHASE2 · Recruiting · Emory University · Atlanta, Georgia